Biolargo Inc (BLGO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
14921 CHESTNUT ST. WESTMINSTER, CA 92683 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 28 - Chemicals And Allied Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,548 | 3,539 | 1,851 | 962 | 716 | 655 | |||
| Cash and cash equivalent | 3,548 | 3,539 | 1,851 | 962 | 716 | 655 | |||
| Receivables | 3,168 | 2,612 | 1,064 | 513 | 484 | 355 | |||
| Inventory, net of allowances, customer advances and progress billings | 330 | 153 | 120 | 241 | 277 | 16 | |||
| Inventory | 330 | 153 | 120 | 241 | 277 | 16 | |||
| Other undisclosed current assets | 91 | 58 | 118 | 85 | 28 | 39 | |||
| Total current assets: | 7,137 | 6,362 | 3,153 | 1,801 | 1,505 | 1,065 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 451 | ||||||||
| Operating lease, right-of-use asset | 992 | 1,092 | 867 | 453 | 341 | 411 | |||
| Property, plant and equipment | 1,742 | 662 | 287 | 61 | 60 | 95 | |||
| Long-term investments and receivables | 96 | 19 | 33 | 48 | 63 | ||||
| Long-term investments | 14 | 19 | 33 | 48 | 63 | ||||
| Accounts and financing receivable, after allowance for credit loss | 82 | ||||||||
| Intangible assets, net (including goodwill) | 2,150 | 1,893 | |||||||
| Intangible assets, net (excluding goodwill) | 2,150 | 1,893 | |||||||
| Prepaid expense | 394 | 591 | 788 | ||||||
| Other noncurrent assets | 95 | 70 | 124 | 69 | 35 | 35 | |||
| Other undisclosed noncurrent assets | 122 | ||||||||
| Total noncurrent assets: | 3,376 | 1,843 | 1,705 | 1,222 | 3,437 | 2,556 | |||
| TOTAL ASSETS: | 10,513 | 8,205 | 4,858 | 3,023 | 4,942 | 3,621 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 946 | 1,488 | 940 | 559 | 513 | 602 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 25 | 42 | 125 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 184 | 156 | 12 | ||
| Accounts payable | 826 | 1,212 | 717 | 350 | 315 | 465 | |||
| Accrued liabilities | 120 | 276 | 223 | ||||||
| Deferred revenue | 303 | 17 | 89 | 48 | 35 | ||||
| Debt | 640 | 66 | 100 | 314 | 1,206 | 5,064 | |||
| Other undisclosed current liabilities | 1,062 | 853 | 519 | 412 | 1,777 | (1,347) | |||
| Total current liabilities: | 2,648 | 2,710 | 1,576 | 1,374 | 3,544 | 4,354 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 360 | 289 | 237 | 529 | 733 | 986 | |||
| Long-term debt, excluding current maturities | 289 | 237 | 180 | 507 | 700 | ||||
| Finance lease, liability | 360 | ||||||||
| Liabilities, other than long-term debt | 922 | 1,004 | 773 | 900 | |||||
| Financial instruments subject to mandatory redemption, settlement terms, share value, amount | 900 | ||||||||
| Operating lease, liability | 922 | 1,004 | 773 | 349 | 226 | 286 | |||
| Other undisclosed noncurrent liabilities | 527 | 261 | (162) | 461 | |||||
| Total noncurrent liabilities: | 1,809 | 1,293 | 1,271 | 716 | 1,633 | 1,447 | |||
| Total liabilities: | 4,457 | 4,003 | 2,847 | 2,090 | 5,177 | 5,801 | |||
| Equity | |||||||||
| Equity, attributable to parent | 8,851 | 6,844 | 4,878 | 4,653 | 3,858 | (2,153) | |||
| Common stock | 202 | 196 | 186 | 171 | 151 | 111 | |||
| Additional paid in capital | 158,332 | 154,023 | 148,435 | 143,718 | 135,849 | 121,327 | |||
| Accumulated other comprehensive loss | (183) | (277) | (149) | (115) | (101) | (99) | |||
| Accumulated deficit | (149,500) | (147,098) | (143,594) | (139,121) | (132,041) | (123,492) | |||
| Equity, attributable to noncontrolling interest | (2,795) | (2,642) | (2,867) | (3,720) | (4,093) | (27) | |||
| Total equity: | 6,056 | 4,202 | 2,011 | 933 | (235) | (2,180) | |||
| TOTAL LIABILITIES AND EQUITY: | 10,513 | 8,205 | 4,858 | 3,023 | 4,942 | 3,621 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 17,779 | 12,230 | 5,884 | 2,531 | 2,432 | 1,861 | ||
| Cost of revenue (Cost of Product and Service Sold) | (9,926) | (6,076) | (3,027) | (1,428) | (1,204) | (945) | ||
| Gross profit: | 7,853 | 6,154 | 2,857 | 1,103 | 1,228 | 916 | ||
| Operating expenses | (12,184) | (10,734) | (8,247) | (7,539) | (8,811) | (7,612) | ||
| Operating loss: | (4,331) | (4,580) | (5,390) | (6,436) | (7,583) | (6,696) | ||
| Nonoperating income (expense) | (16) | (68) | 258 | (458) | (2,117) | (4,744) | ||
| Investment income, nonoperating | ||||||||
| Government assistance, nonoperating income, increase (decrease) | 26 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other nonoperating income (expense) | (68) | 258 | (458) | (2,117) | (4,744) | |||
| Interest and debt expense | (66) | (91) | (53) | (234) | (2,365) | (1,029) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (4,413) | (4,739) | (5,185) | (7,128) | (12,065) | (12,469) | ||
| Loss from equity method investments | (15) | (37) | ||||||
| Loss from continuing operations: | (4,413) | (4,739) | (5,185) | (7,143) | (12,102) | (12,469) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (7,143) | (12,102) | (12,469) | |
| Other undisclosed net income | 66 | 91 | 53 | 249 | 2,402 | 1,029 | ||
| Net loss: | (4,347) | (4,648) | (5,132) | (6,894) | (9,700) | (11,440) | ||
| Net income attributable to noncontrolling interest | 1,945 | 1,144 | 659 | |||||
| Net loss attributable to parent: | (2,402) | (3,504) | (4,473) | (6,894) | (9,700) | (11,440) | ||
| Other undisclosed net income (loss) available to common stockholders, basic | (186) | 1,268 | 750 | |||||
| Net loss available to common stockholders, diluted: | (2,402) | (3,504) | (4,473) | (7,080) | (8,432) | (10,690) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (4,347) | (4,648) | (5,132) | (6,894) | (9,700) | (11,440) | ||
| Other undisclosed comprehensive income (loss) | 94 | (128) | (34) | (14) | (2) | (9) | ||
| Comprehensive loss: | (4,253) | (4,776) | (5,166) | (6,908) | (9,702) | (11,449) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 1,945 | 1,144 | 659 | (186) | 1,268 | 750 | ||
| Comprehensive loss, net of tax, attributable to parent: | (2,308) | (3,632) | (4,507) | (7,094) | (8,434) | (10,699) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.